Status:
UNKNOWN
Treatment of Sudden Deafness With Prednisone+Hyperbaric Oxygen and Prednisone+Somatosensory Stimulation
Lead Sponsor:
Dan Su
Conditions:
Hearing Loss, Sudden
Prednisone Acetate
Eligibility:
All Genders
14-80 years
Phase:
NA
Brief Summary
To study the effective treatment of sudden deafness by giving prednisone, hyperbaric oxygen and somatosensory stimulation to sudden deafness patients.
Detailed Description
60 cases of sudden deafness within 2 months of 14-80 years old were randomly divided into two groups. They underwent hearing tests, magnetic resonance imaging of the head, and routine hospital admissi...
Eligibility Criteria
Inclusion
- Sudden deafness
- History within 2 months
- Age 14-80
Exclusion
- Neurological diseases (such as brain tumors)
- Patients with mental / mental illness undergoing treatment
- Pregnant women and patients with other untreatable diseases
- Finding the cause of sensorineural deafness
- Patients Not Suitable for Hyperbaric Oxygen
- A patient with dermatosis
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04129983
Start Date
June 1 2020
End Date
October 1 2020
Last Update
February 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
E.N.T. department of the First Affiliated hospital of Anhui Medical University
Hefei, Anhui, China, 230000